Results 11 to 20 of about 37,328 (240)
Swiss Medical Weekly, 2012 Malignant hyperthermia (MH) is a subclinical myopathy, usually triggered by volatile anaesthetics and depolarising muscle relaxants. Clinical symptoms are variable, and the condition is sometimes difficult to identify.
Oliver Bandschapp, Thierry Girard
doaj +9 more sources
Orphanet Journal of Rare Diseases, 2007 Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine ...
Pollock Neil +4 more
doaj +3 more sources
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022 Malignant hyperthermia manifests as hypermetabolism of striated voluntary muscle. Generally, this condition occurs during general anesthesia when inhalational anesthetics and succinylcholine are used.
S. N. Ionov +2 more
doaj +4 more sources
Malignant hyperthermia: patient undergoing limb debridement surgery—a case report [PDF]
Journal of Medical Case ReportsBackground Malignant hyperthermia is a rare but potentially fatal clinical emergency, primarily triggered by inhaled volatile anesthetics. It is associated with inherited autosomal-dominant skeletal muscle disorders and typically caused by mutations in ...
Zhixiang Geng +6 more
doaj +2 more sources
Successful management of malignant hyperthermia without dantrolene: A case report [PDF]
Journal of International Medical ResearchMalignant hyperthermia during surgery represents a significant challenge for anesthesiologists due to its high mortality rate and the risk of long-term physiological damage.
Cailing Zhang +3 more
doaj +2 more sources
Keeping it in the family: malignant hyperthermia - how we predict, recognise and treat it [PDF]
Brazilian Journal of AnesthesiologyJonathan G. Bilmen, Pawan K. Gupta
doaj +2 more sources
JAI (Jurnal Anestesiologi Indonesia)Malignant hyperthermia (MH) is a life-threatening clinical syndrome caused by hypermetabolism involving skeletal muscle. MH is very rare, but it is one of the causes of death in the operating room. MH is an autosomal dominant disease and can be triggered
Doni Fajri +2 more
doaj +2 more sources
Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapy [PDF]
BMC PsychiatryBackground Malignant hyperthermia is a potentially lethal condition triggered by specific anesthetic drugs, especially a depolarizing muscle relaxant of succinylcholine (Suxamethonium).
Masaki Nakano +8 more
doaj +2 more sources
Acute postoperative sepsis mimicking symptomology suspicious for malignant hyperthermia: case report [PDF]
Revista Brasileira de Anestesiologia, 2020 Background: Sepsis is a life-threatening organ dysfunction with non-specific clinical features that can mimic other clinical conditions with hyper metabolic state such as malignant hyperthermia.
Vendhan Ramanujam +3 more
doaj +5 more sources
Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil [PDF]
Revista Brasileira de Anestesiologia, 2019 Background and objectives: Malignant hyperthermia is an autosomal dominant hypermetabolic pharmacogenetic syndrome, with a mortality rate of 10%–20%, which is triggered by the use of halogenated inhaled anesthetics or muscle relaxant succinylcholine. The
Helga Cristina Almeida da Silva +7 more
doaj +5 more sources